| Literature DB >> 28441273 |
Abstract
: This case report describes the development of dependence to phenibut, a gamma-aminobutyric acid-receptor type B agonist, in a patient concurrently being treated with buprenorphine. The patient experienced withdrawal symptoms which were successfully treated with a phenobarbital taper based on a protocol to treat sedative use disorder. This case report provided an example of the development of a phenibut use disorder and also brought up a public health question of whether phenibut should therefore be officially classified and monitored.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28441273 DOI: 10.1097/ADM.0000000000000303
Source DB: PubMed Journal: J Addict Med ISSN: 1932-0620 Impact factor: 3.702